Advances in Therapeutic Strategies for the Management of <i>Clostridioides difficile</i> Infection

Advances in Therapeutic Strategies for the Management of <i>Clostridioides difficile</i> Infection

The infection caused by <i>Clostridioides difficile</i> represents one of the bacterial infections with the greatest increase in incidence among nosocomial infections in recent years. <i>C. difficile</i> is a Gram-positive bacterium able to produce toxins and spores. In some...

Full description

Bibliographic Details
Main Authors:	Antonio Vitiello, Michela Sabbatucci, Andrea Zovi, Antonio Salzano, Annarita Ponzo, Mariarosaria Boccellino
Format:	Article
Language:	English
Published:	MDPI AG 2024-02-01
Series:	Journal of Clinical Medicine
Subjects:	<i>Clostridioides difficile</i> CDI healthcare-associated infection antibiotics monoclonal antibodies phages
Online Access:	https://www.mdpi.com/2077-0383/13/5/1331

Similar Items

Influence of Probiotics on the Development of <i>Clostridioides difficile</i> Infection in Patients Receiving Fluoroquinolones
by: Mary E. Sheffield, et al.
Published: (2021-08-01)

Fidaxomicin for the Treatment of <i>Clostridioides difficile</i> Infection in Adult Patients: An Update on Results from Randomized Controlled Trials
by: Daniele Roberto Giacobbe, et al.
Published: (2022-10-01)

Bezlotoxumab in Patients with a Primary <i>Clostridioides difficile</i> Infection: A Literature Review
by: Guido Granata, et al.
Published: (2022-10-01)

The Risk of <i>Clostridioides difficile</i> Recurrence after Initial Treatment with Vancomycin or Fidaxomicin Utilizing Cerner Health Facts
by: Ronald G. Hall, et al.
Published: (2022-02-01)

Assessing the Feasibility of Employing a Combination of a Bacteriophage-Derived Endolysin and Spore Germinants to Treat Relapsing <i>Clostridioides difficile</i> Infection
by: Khalid Alyahya, et al.
Published: (2023-06-01)

The Role of Bezlotoxumab for the Prevention of Recurrent <i>Clostridioides difficile</i> Infections: A Review of the Current Literature and Paradigm Shift after 2021
by: Melanie L. Hyte, et al.
Published: (2022-09-01)

A Real-World Study on the Clinical Characteristics, Outcomes, and Relationship between Antibiotic Exposure and <i>Clostridioides difficile</i> Infection
by: Bogdan Ioan Vintila, et al.
Published: (2024-02-01)

Diversity, Dynamics and Therapeutic Application of <i>Clostridioides difficile</i> Bacteriophages
by: Janet Y. Nale, et al.
Published: (2022-12-01)

National Surveillance for Clostridioides difficile Infection, Sweden, 2009–2016
by: Kristina Rizzardi, et al.
Published: (2018-09-01)

High Prevalence of <i>Clostridioides difficile</i> Ribotype 176 in the University Hospital in Kosice
by: Katarina Curova, et al.
Published: (2023-03-01)

Clinical characteristics associated with the severity of Clostridium [Clostridioides] difficile infection in a tertiary teaching hospital from Mexico
by: Laura Tijerina-Rodríguez, et al.
Published: (2022-02-01)

Trends in and Risk Factors for Recurrent Clostridioides difficile Infection, New Haven County, Connecticut, USA, 2015–2020
by: Chinenye M. Okafor, et al.
Published: (2023-05-01)

Microbiota in <i>Clostridioides difficile</i>-Associated Diarrhea: Comparison in Recurrent and Non-Recurrent Infections
by: Alessandra Gazzola, et al.
Published: (2020-09-01)

Editorial: Clostridioides difficile infection
by: Guido Granata, et al.
Published: (2024-02-01)

<i>Clostridioides difficile</i> in Pigs and Dairy Cattle in Northern Italy: Prevalence, Characterization and Comparison between Animal and Human Strains
by: Patrizia Spigaglia, et al.
Published: (2023-07-01)

Clostridioides difficile infection in infants: a case report and literature review
by: Zhirong Li, et al.
Published: (2023-06-01)

Systematic review of guidelines for the diagnosis and treatment of Clostridioides difficile infection
by: Ting Gu, et al.
Published: (2022-08-01)

Investigational Treatment Agents for Recurrent Clostridioides difficile Infection (rCDI)
by: Kullar R, et al.
Published: (2020-10-01)

Teicoplanin Suppresses Vegetative <i>Clostridioides difficile</i> and Spore Outgrowth
by: Suvash Chandra Ojha, et al.
Published: (2021-08-01)

Prevalence, antibiogram, phenotypic and genotypic analysis of Clostridioides difficile toxigenic strains from stool samples
by: Mohammed A. Alqasem, et al.
Published: (2023-08-01)

SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent <i>Clostridioides difficile</i> Infection (rCDI)
by: Sahil Khanna, et al.
Published: (2022-09-01)

Laboratory markers predictive of fulminant Clostridioides difficile infection refractory to fluid resuscitation
by: Omar Ahmad, et al.
Published: (2021-06-01)

<i>Clostridioides difficile</i> Flagella
by: Jean-Christophe Marvaud, et al.
Published: (2024-02-01)

ESTRATÉGIAS PARA REDUÇÃO DOS CASOS DE CLOSTRIDIOIDES DIFFICILE NA UNIDADE DE TERAPIA INTENSIVA: ABORDAGEM MULTIFATORIAL
by: Luciana Rodrigues da Silva, et al.
Published: (2023-10-01)

Characterization of a Clostridioides difficile outbreak caused by PCR ribotype 046, associated with increased mortality
by: Cecilia Magnusson, et al.
Published: (2022-12-01)

Description of antibiotic treatment in adults tested for Clostridioides difficile infection: a single-center case–control study
by: Min Hyung Kim, et al.
Published: (2022-01-01)

Fecal Microbiota of Toxigenic Clostridioides difficile-Associated Diarrhea
by: Marta Hernández, et al.
Published: (2019-01-01)

Prevalence of Non-Toxigenic <i>Clostridioides difficile</i> in Diarrhoea Patients and Their Clinical Characteristics
by: Cheon-Hoo Jeon, et al.
Published: (2023-08-01)

A Prediction Model Incorporating Peripheral Eosinopenia as a Novel Risk Factor for Death After Hospitalization for Clostridioides difficile Infection
by: Ying Wang, et al.
Published: (2022-01-01)

Whole Genome Sequencing Evidences High Rates of Relapse in <i>Clostridioides difficile</i> Infection Caused by the Epidemic Ribotype 106
by: Loreto Suárez-Bode, et al.
Published: (2023-01-01)

Anti-S-layer monoclonal antibodies impact Clostridioides difficile physiology
by: Lise Hunault, et al.
Published: (2024-12-01)

<i>In Vitro</i> Bactericidal Effects of Photodynamic Therapy Combined with Four Tetracyclines against <i>Clostridioides difficile</i> KCTC5009 in Planktonic Cultures
by: Sung Sook Choi, et al.
Published: (2020-04-01)

Early Life Antimicrobial Exposure: Impact on <i>Clostridioides difficile</i> Colonization in Infants
by: Chinwe Vivien Obiakor, et al.
Published: (2022-07-01)

The Efficacy of Faecal Microbiota Transplant and Rectal Bacteriotherapy in Patients with Recurrent <i>Clostridioides difficile</i> Infection: A Retrospective Cohort Study
by: Camilla Kara Svensson, et al.
Published: (2022-10-01)

Gut Microbiota Composition Associated with <i>Clostridioides difficile</i> Colonization and Infection
by: Elisa Martinez, et al.
Published: (2022-07-01)

Genomic and Phenotypic Characterization of the Nontoxigenic Clostridioides difficile Strain CCUG37785 and Demonstration of Its Therapeutic Potential for the Prevention of C. difficile Infection
by: Shaohui Wang, et al.
Published: (2022-04-01)

Usefulness of Fecal Calprotectin in the Management of Patients with Toxigenic <i>Clostridioides difficile</i>
by: Cecilia Suarez-Carantoña, et al.
Published: (2021-04-01)

Gut microbiota and microbiota-based therapies for Clostridioides difficile infection
by: Teena Chopra, et al.
Published: (2023-01-01)

Nitro-Group-Containing Thiopeptide Derivatives as Promising Agents to Target <i>Clostridioides difficile</i>
by: Dahyun Kim, et al.
Published: (2022-05-01)

Pragmatic Strategy for Fecal Specimen Storage and the Corresponding Test Methods for <i>Clostridioides difficile</i> Diagnosis
by: Seong Won Nho, et al.
Published: (2021-08-01)